Drug Interactions of Psychiatric and COVID-19 Medications.
Identifieur interne : 000852 ( Main/Exploration ); précédent : 000851; suivant : 000853Drug Interactions of Psychiatric and COVID-19 Medications.
Auteurs : Niayesh Mohebbi [Iran] ; Ali Talebi [Iran] ; Marjan Moghadamnia [Iran] ; Zahra Nazari Taloki [Iran] ; Alia Shakiba [Iran]Source :
- Basic and clinical neuroscience [ 2008-126X ]
Abstract
Introduction
Coronavirus disease 2019 (COVID-19) has become a pandemic with 1771514 cases identified in the world and 70029 cases in Iran until April 12, 2020. The co-prescription of psychotropics with COVID-19 medication is not uncommon. Healthcare providers should be familiar with many Potential Drug-Drug Interactions (DDIs) between COVID-19 therapeutic agents and psychotropic drugs based on cytochrome P450 metabolism. This review comprehensively summarizes the current literature on DDIs between antiretroviral drugs and chloroquine/hydroxychloroquine, and psychotropics, including antidepressants, antipsychotics, mood stabilizers, and anxiolytics.
Methods
Medical databases, including Google Scholar, PubMed, Web of Science, and Scopus were searched to identify studies in English with keywords related to psychiatric disorders, medications used in the treatment of psychiatric disorders and COVID-19 medications.
Results
There is a great potential for DDIs between psychiatric and COVID-19 medications ranging from interactions that are not clinically apparent (minor) to those that produce life-threatening adverse drug reactions, or loss of treatment efficacy. The majority of interactions are pharmacokinetic interactions via the cytochrome P450 enzyme system.
Conclusion
DDIs are a major concern in the comorbidity of psychiatric disorders and COVID-19 infection resulting in the alteration of expected therapeutic outcomes. The risk of toxicity or lack of efficacy may occur due to a higher or lower plasma concentration of medications. However, psychiatric medication can be safely used in combination with COVID-19 pharmacotherapy with either a wise selection of medication with the least possibility of interaction or careful patient monitoring and management.
DOI: 10.32598/bcn.11.covid19.2500.1
PubMed: 32855778
PubMed Central: PMC7368108
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Drug Interactions of Psychiatric and COVID-19 Medications.</title><author><name sortKey="Mohebbi, Niayesh" sort="Mohebbi, Niayesh" uniqKey="Mohebbi N" first="Niayesh" last="Mohebbi">Niayesh Mohebbi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran</wicri:regionArea><wicri:noRegion>Tehran</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>Research Center for Rational Use of Drugs; Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Research Center for Rational Use of Drugs; Tehran University of Medical Sciences, Tehran</wicri:regionArea><wicri:noRegion>Tehran</wicri:noRegion></affiliation></author><author><name sortKey="Talebi, Ali" sort="Talebi, Ali" uniqKey="Talebi A" first="Ali" last="Talebi">Ali Talebi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran</wicri:regionArea><wicri:noRegion>Tehran</wicri:noRegion></affiliation></author><author><name sortKey="Moghadamnia, Marjan" sort="Moghadamnia, Marjan" uniqKey="Moghadamnia M" first="Marjan" last="Moghadamnia">Marjan Moghadamnia</name><affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran</wicri:regionArea><wicri:noRegion>Tehran</wicri:noRegion></affiliation></author><author><name sortKey="Nazari Taloki, Zahra" sort="Nazari Taloki, Zahra" uniqKey="Nazari Taloki Z" first="Zahra" last="Nazari Taloki">Zahra Nazari Taloki</name><affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran</wicri:regionArea><wicri:noRegion>Tehran</wicri:noRegion></affiliation></author><author><name sortKey="Shakiba, Alia" sort="Shakiba, Alia" uniqKey="Shakiba A" first="Alia" last="Shakiba">Alia Shakiba</name><affiliation wicri:level="1"><nlm:affiliation>Department of Psychiatry, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Department of Psychiatry, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran</wicri:regionArea><wicri:noRegion>Tehran</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020 Mar-Apr</date><idno type="RBID">pubmed:32855778</idno><idno type="pmid">32855778</idno><idno type="doi">10.32598/bcn.11.covid19.2500.1</idno><idno type="pmc">PMC7368108</idno><idno type="wicri:Area/Main/Corpus">000D65</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000D65</idno><idno type="wicri:Area/Main/Curation">000D65</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000D65</idno><idno type="wicri:Area/Main/Exploration">000D65</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Drug Interactions of Psychiatric and COVID-19 Medications.</title><author><name sortKey="Mohebbi, Niayesh" sort="Mohebbi, Niayesh" uniqKey="Mohebbi N" first="Niayesh" last="Mohebbi">Niayesh Mohebbi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran</wicri:regionArea><wicri:noRegion>Tehran</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>Research Center for Rational Use of Drugs; Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Research Center for Rational Use of Drugs; Tehran University of Medical Sciences, Tehran</wicri:regionArea><wicri:noRegion>Tehran</wicri:noRegion></affiliation></author><author><name sortKey="Talebi, Ali" sort="Talebi, Ali" uniqKey="Talebi A" first="Ali" last="Talebi">Ali Talebi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran</wicri:regionArea><wicri:noRegion>Tehran</wicri:noRegion></affiliation></author><author><name sortKey="Moghadamnia, Marjan" sort="Moghadamnia, Marjan" uniqKey="Moghadamnia M" first="Marjan" last="Moghadamnia">Marjan Moghadamnia</name><affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran</wicri:regionArea><wicri:noRegion>Tehran</wicri:noRegion></affiliation></author><author><name sortKey="Nazari Taloki, Zahra" sort="Nazari Taloki, Zahra" uniqKey="Nazari Taloki Z" first="Zahra" last="Nazari Taloki">Zahra Nazari Taloki</name><affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran</wicri:regionArea><wicri:noRegion>Tehran</wicri:noRegion></affiliation></author><author><name sortKey="Shakiba, Alia" sort="Shakiba, Alia" uniqKey="Shakiba A" first="Alia" last="Shakiba">Alia Shakiba</name><affiliation wicri:level="1"><nlm:affiliation>Department of Psychiatry, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Department of Psychiatry, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran</wicri:regionArea><wicri:noRegion>Tehran</wicri:noRegion></affiliation></author></analytic><series><title level="j">Basic and clinical neuroscience</title><idno type="ISSN">2008-126X</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>Introduction</b></p><p>Coronavirus disease 2019 (COVID-19) has become a pandemic with 1771514 cases identified in the world and 70029 cases in Iran until April 12, 2020. The co-prescription of psychotropics with COVID-19 medication is not uncommon. Healthcare providers should be familiar with many Potential Drug-Drug Interactions (DDIs) between COVID-19 therapeutic agents and psychotropic drugs based on cytochrome P450 metabolism. This review comprehensively summarizes the current literature on DDIs between antiretroviral drugs and chloroquine/hydroxychloroquine, and psychotropics, including antidepressants, antipsychotics, mood stabilizers, and anxiolytics.</p></div><div type="abstract" xml:lang="en"><p><b>Methods</b></p><p>Medical databases, including Google Scholar, PubMed, Web of Science, and Scopus were searched to identify studies in English with keywords related to psychiatric disorders, medications used in the treatment of psychiatric disorders and COVID-19 medications.</p></div><div type="abstract" xml:lang="en"><p><b>Results</b></p><p>There is a great potential for DDIs between psychiatric and COVID-19 medications ranging from interactions that are not clinically apparent (minor) to those that produce life-threatening adverse drug reactions, or loss of treatment efficacy. The majority of interactions are pharmacokinetic interactions via the cytochrome P450 enzyme system.</p></div><div type="abstract" xml:lang="en"><p><b>Conclusion</b></p><p>DDIs are a major concern in the comorbidity of psychiatric disorders and COVID-19 infection resulting in the alteration of expected therapeutic outcomes. The risk of toxicity or lack of efficacy may occur due to a higher or lower plasma concentration of medications. However, psychiatric medication can be safely used in combination with COVID-19 pharmacotherapy with either a wise selection of medication with the least possibility of interaction or careful patient monitoring and management.</p></div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32855778</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2008-126X</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>2</Issue><PubDate><MedlineDate>2020 Mar-Apr</MedlineDate></PubDate></JournalIssue><Title>Basic and clinical neuroscience</Title><ISOAbbreviation>Basic Clin Neurosci</ISOAbbreviation></Journal><ArticleTitle>Drug Interactions of Psychiatric and COVID-19 Medications.</ArticleTitle><Pagination><MedlinePgn>185-200</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.32598/bcn.11.covid19.2500.1</ELocationID><Abstract><AbstractText Label="Introduction" NlmCategory="UNASSIGNED">Coronavirus disease 2019 (COVID-19) has become a pandemic with 1771514 cases identified in the world and 70029 cases in Iran until April 12, 2020. The co-prescription of psychotropics with COVID-19 medication is not uncommon. Healthcare providers should be familiar with many Potential Drug-Drug Interactions (DDIs) between COVID-19 therapeutic agents and psychotropic drugs based on cytochrome P450 metabolism. This review comprehensively summarizes the current literature on DDIs between antiretroviral drugs and chloroquine/hydroxychloroquine, and psychotropics, including antidepressants, antipsychotics, mood stabilizers, and anxiolytics.</AbstractText><AbstractText Label="Methods" NlmCategory="UNASSIGNED">Medical databases, including Google Scholar, PubMed, Web of Science, and Scopus were searched to identify studies in English with keywords related to psychiatric disorders, medications used in the treatment of psychiatric disorders and COVID-19 medications.</AbstractText><AbstractText Label="Results" NlmCategory="UNASSIGNED">There is a great potential for DDIs between psychiatric and COVID-19 medications ranging from interactions that are not clinically apparent (minor) to those that produce life-threatening adverse drug reactions, or loss of treatment efficacy. The majority of interactions are pharmacokinetic interactions via the cytochrome P450 enzyme system.</AbstractText><AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">DDIs are a major concern in the comorbidity of psychiatric disorders and COVID-19 infection resulting in the alteration of expected therapeutic outcomes. The risk of toxicity or lack of efficacy may occur due to a higher or lower plasma concentration of medications. However, psychiatric medication can be safely used in combination with COVID-19 pharmacotherapy with either a wise selection of medication with the least possibility of interaction or careful patient monitoring and management.</AbstractText><CopyrightInformation>Copyright© 2020 Iranian Neuroscience Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mohebbi</LastName><ForeName>Niayesh</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-1420-7286</Identifier><AffiliationInfo><Affiliation>Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center for Rational Use of Drugs; Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Talebi</LastName><ForeName>Ali</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2936-453X</Identifier><AffiliationInfo><Affiliation>Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moghadamnia</LastName><ForeName>Marjan</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0459-1042</Identifier><AffiliationInfo><Affiliation>Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nazari Taloki</LastName><ForeName>Zahra</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-7919-9192</Identifier><AffiliationInfo><Affiliation>Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shakiba</LastName><ForeName>Alia</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-5720-8900</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Iran</Country><MedlineTA>Basic Clin Neurosci</MedlineTA><NlmUniqueID>101575211</NlmUniqueID><ISSNLinking>2008-126X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antidepressants</Keyword><Keyword MajorTopicYN="N">Antipsychotics</Keyword><Keyword MajorTopicYN="N">Anxiolytics</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Chloroquine</Keyword><Keyword MajorTopicYN="N">Drug interaction</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>04</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>04</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>04</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32855778</ArticleId><ArticleId IdType="doi">10.32598/bcn.11.covid19.2500.1</ArticleId><ArticleId IdType="pii">BCN-11-185</ArticleId><ArticleId IdType="pmc">PMC7368108</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Malar J. 2016 May 17;15(1):280</Citation><ArticleIdList><ArticleId IdType="pubmed">27188854</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1958 Nov;115(5):459-64</Citation><ArticleIdList><ArticleId IdType="pubmed">13583250</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Clin Pharmacol. 2008 May;64(5):531-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18196226</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Drug Metab. 2010 Nov;11(9):815-29</Citation><ArticleIdList><ArticleId IdType="pubmed">21189133</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacol Res. 2016 Apr;106:72-86</Citation><ArticleIdList><ArticleId IdType="pubmed">26896788</ArticleId></ArticleIdList></Reference><Reference><Citation>J Acquir Immune Defic Syndr. 2004 Aug 15;36(5):1034-40</Citation><ArticleIdList><ArticleId IdType="pubmed">15247556</ArticleId></ArticleIdList></Reference><Reference><Citation>J Acquir Immune Defic Syndr. 2008 Dec 1;49(4):358-68</Citation><ArticleIdList><ArticleId IdType="pubmed">19186349</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Pharmacol. 1989 Jul;36(1):89-96</Citation><ArticleIdList><ArticleId IdType="pubmed">2787473</ArticleId></ArticleIdList></Reference><Reference><Citation>Br Med J (Clin Res Ed). 1986 May 17;292(6531):1319-21</Citation><ArticleIdList><ArticleId IdType="pubmed">3085830</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychopharmacol. 1999 Aug;19(4):293-6</Citation><ArticleIdList><ArticleId IdType="pubmed">10440454</ArticleId></ArticleIdList></Reference><Reference><Citation>Antimicrob Agents Chemother. 2008 May;52(5):1663-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18285471</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Biophys Res Commun. 2013 Jun 14;435(4):708-13</Citation><ArticleIdList><ArticleId IdType="pubmed">23702482</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pharmacokinet. 2011 Jan;50(1):25-39</Citation><ArticleIdList><ArticleId IdType="pubmed">21142266</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 1997;58 Suppl 5:7-14</Citation><ArticleIdList><ArticleId IdType="pubmed">9184622</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Antimicrob Agents. 2014 Aug;44(2):173-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24929949</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Pharmacol. 2003 Apr;43(4):414-22</Citation><ArticleIdList><ArticleId IdType="pubmed">12723462</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Clin Pharmacol. 2007 Dec;63(12):1147-51</Citation><ArticleIdList><ArticleId IdType="pubmed">17828532</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pharmacokinet. 1996 Oct;31(4):257-74</Citation><ArticleIdList><ArticleId IdType="pubmed">8896943</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1999 Jun;156(6):969-70</Citation><ArticleIdList><ArticleId IdType="pubmed">10360146</ArticleId></ArticleIdList></Reference><Reference><Citation>Antimicrob Agents Chemother. 2004 Nov;48(11):4328-31</Citation><ArticleIdList><ArticleId IdType="pubmed">15504860</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Drug Metab. 2010 Jul;11(6):516-25</Citation><ArticleIdList><ArticleId IdType="pubmed">20540690</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Pharmacother. 2003 Feb;37(2):202-5</Citation><ArticleIdList><ArticleId IdType="pubmed">12549947</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Metab Dispos. 2003 Jul;31(7):815-32</Citation><ArticleIdList><ArticleId IdType="pubmed">12814957</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Apr 30;382(18):1708-1720</Citation><ArticleIdList><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Neurol Scand. 2008 Aug;118(2):69-86</Citation><ArticleIdList><ArticleId IdType="pubmed">18384456</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychopharmacol. 2002 Apr;22(2):169-73</Citation><ArticleIdList><ArticleId IdType="pubmed">11910262</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychopharmacol. 2004 Aug;24(4):386-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15232329</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacotherapy. 2001 Feb;21(2):163-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11213852</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2004 Oct;78(19):10410-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15367607</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Med Interne. 2010 Feb;31(2):170-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19740579</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Antimicrob Agents. 2020 Mar;55(3):105924</Citation><ArticleIdList><ArticleId IdType="pubmed">32081636</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Ther. 2014 Nov 1;36(11):1638-49</Citation><ArticleIdList><ArticleId IdType="pubmed">25236915</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurotoxicology. 2004 Jan;25(1-2):215-21</Citation><ArticleIdList><ArticleId IdType="pubmed">14697896</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Ther. 2003 Apr;25(4):1200-10</Citation><ArticleIdList><ArticleId IdType="pubmed">12809966</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pharmacokinet. 2016 Dec;55(12):1471-1494</Citation><ArticleIdList><ArticleId IdType="pubmed">27317413</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Metab Dispos. 2001 Aug;29(8):1102-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11454728</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pharmacol Ther. 2008 Jul;84(1):75-82</Citation><ArticleIdList><ArticleId IdType="pubmed">18183034</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2002 Sep 3;137(5 Pt 2):381-433</Citation><ArticleIdList><ArticleId IdType="pubmed">12617573</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Clin Pharmacol. 2012 Jan;68(1):29-37</Citation><ArticleIdList><ArticleId IdType="pubmed">21739267</ArticleId></ArticleIdList></Reference><Reference><Citation>Antimicrob Agents Chemother. 1998 Dec;42(12):3107-12</Citation><ArticleIdList><ArticleId IdType="pubmed">9835499</ArticleId></ArticleIdList></Reference><Reference><Citation>J Interv Card Electrophysiol. 2007 Apr;18(3):243-6</Citation><ArticleIdList><ArticleId IdType="pubmed">17546486</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Ther. 2008 Jul;30(7):1206-27</Citation><ArticleIdList><ArticleId IdType="pubmed">18691982</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Pharmacol. 2007 Jul;151(6):737-48</Citation><ArticleIdList><ArticleId IdType="pubmed">17471183</ArticleId></ArticleIdList></Reference><Reference><Citation>CNS Drugs. 2003;17(7):513-32</Citation><ArticleIdList><ArticleId IdType="pubmed">12751920</ArticleId></ArticleIdList></Reference><Reference><Citation>J Assoc Physicians India. 1995 Jan;43(1):17-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9282631</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Metab Dispos. 2003 Jun;31(6):748-54</Citation><ArticleIdList><ArticleId IdType="pubmed">12756207</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Pharmacother. 2013 Jan;47(1):75-89</Citation><ArticleIdList><ArticleId IdType="pubmed">23341158</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Pharmacother. 2006 Jan;40(1):147-50</Citation><ArticleIdList><ArticleId IdType="pubmed">16368918</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2008 Mar;47(3):378-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18222983</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pharmacokinet. 1998 Oct;35(4):275-91</Citation><ArticleIdList><ArticleId IdType="pubmed">9812178</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2006 May 1;42(9):1305-10</Citation><ArticleIdList><ArticleId IdType="pubmed">16586391</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013 Oct 30;8(10):e76799</Citation><ArticleIdList><ArticleId IdType="pubmed">24204676</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2020 Feb 24;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Pharmacol. 2003 May 1;65(9):1441-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12732356</ArticleId></ArticleIdList></Reference><Reference><Citation>J Acquir Immune Defic Syndr. 2006 May;42(1):52-60</Citation><ArticleIdList><ArticleId IdType="pubmed">16639344</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Pharm Des. 2015;21(23):3343-51</Citation><ArticleIdList><ArticleId IdType="pubmed">26088119</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Biol Sci. 2020 Mar 15;16(10):1732-1738</Citation><ArticleIdList><ArticleId IdType="pubmed">32226291</ArticleId></ArticleIdList></Reference><Reference><Citation>CNS Spectr. 2019 Jun;24(3):287-312</Citation><ArticleIdList><ArticleId IdType="pubmed">30295215</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc (Bayl Univ Med Cent). 2000 Oct;13(4):421-3</Citation><ArticleIdList><ArticleId IdType="pubmed">16389357</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Metab Dispos. 2010 Mar;38(3):376-85</Citation><ArticleIdList><ArticleId IdType="pubmed">20007670</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2000 Apr;157(4 Suppl):1-45</Citation><ArticleIdList><ArticleId IdType="pubmed">10767867</ArticleId></ArticleIdList></Reference><Reference><Citation>Indian J Pharmacol. 2015 Sep-Oct;47(5):567-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26600652</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Toxicol. 2007 Dec;3(4):178-81</Citation><ArticleIdList><ArticleId IdType="pubmed">18072173</ArticleId></ArticleIdList></Reference><Reference><Citation>AIDS. 2001 Jul 6;15(10):1281-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11426073</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pharmacol Ther. 2007 Jan;81(1):69-75</Citation><ArticleIdList><ArticleId IdType="pubmed">17186001</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pharmacol Ther. 2009 Jan;85(1):64-70</Citation><ArticleIdList><ArticleId IdType="pubmed">18815591</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Clin Pharmacol. 2003 Sep;59(5-6):401-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12898080</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Pharmacol. 2006 May;46(5):567-76</Citation><ArticleIdList><ArticleId IdType="pubmed">16638740</ArticleId></ArticleIdList></Reference><Reference><Citation>Trop Geogr Med. 1988 Jan;40(1):31-3</Citation><ArticleIdList><ArticleId IdType="pubmed">3381314</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Sci. 1995 Jun;309(6):315-6</Citation><ArticleIdList><ArticleId IdType="pubmed">7771501</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Neurosci Res. 2002 Dec;2(3-4):193-212</Citation><ArticleIdList><ArticleId IdType="pubmed">22707923</ArticleId></ArticleIdList></Reference><Reference><Citation>Asian J Psychiatr. 2020 Mar;49:101989</Citation><ArticleIdList><ArticleId IdType="pubmed">32143142</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Metab Dispos. 2000 Oct;28(10):1187-91</Citation><ArticleIdList><ArticleId IdType="pubmed">10997938</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Pharmacol. 2013 Jun;53(6):654-61</Citation><ArticleIdList><ArticleId IdType="pubmed">23381882</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pharmacokinet. 1997;32 Suppl 1:1-21</Citation><ArticleIdList><ArticleId IdType="pubmed">9068931</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmaceutics. 2017 Dec 21;10(1):</Citation><ArticleIdList><ArticleId IdType="pubmed">29267251</ArticleId></ArticleIdList></Reference><Reference><Citation>Ochsner J. 2013 Summer;13(2):214-23</Citation><ArticleIdList><ArticleId IdType="pubmed">23789008</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Pharmacol. 2010 Oct;50(10):1180-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20484617</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Acad Child Adolesc Psychiatry. 2002 Sep;41(9):1037-44</Citation><ArticleIdList><ArticleId IdType="pubmed">12218424</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pharmacol Ther. 2006 Aug;80(2):159-68</Citation><ArticleIdList><ArticleId IdType="pubmed">16890577</ArticleId></ArticleIdList></Reference><Reference><Citation>Handb Exp Pharmacol. 2019;250:145-180</Citation><ArticleIdList><ArticleId IdType="pubmed">30838456</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Metab Dispos. 2011 Jun;39(6):1070-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21406602</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacotherapy. 2009 Oct;29(10):1175-81</Citation><ArticleIdList><ArticleId IdType="pubmed">19792991</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 1998 Dec;51(3):237-54</Citation><ArticleIdList><ArticleId IdType="pubmed">10333980</ArticleId></ArticleIdList></Reference><Reference><Citation>J Acquir Immune Defic Syndr. 2000 Jun 1;24(2):129-36</Citation><ArticleIdList><ArticleId IdType="pubmed">10935688</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunopharmacol Immunotoxicol. 2013 Jun;35(3):434-42</Citation><ArticleIdList><ArticleId IdType="pubmed">23635029</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Rheumatol. 2011 Jan;17(1):46-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21169846</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacotherapy. 2009 Nov;29(11):1386-91</Citation><ArticleIdList><ArticleId IdType="pubmed">19857154</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Clin Pharmacol. 2007 Aug;64(2):192-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17298480</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Drug Metab. 2008 Jun;9(5):410-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18537577</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1964 Nov 7;2(7367):995-7</Citation><ArticleIdList><ArticleId IdType="pubmed">14201672</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pharmacokinet. 1995;29 Suppl 1:1-9</Citation><ArticleIdList><ArticleId IdType="pubmed">8846617</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 1999 Jan;26(1):195-6</Citation><ArticleIdList><ArticleId IdType="pubmed">9918262</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychopharmacol. 2005 Jun;25(3):226-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15876900</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pharmacol Ther. 2003 Mar;73(3):170-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12621382</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Neuropharmacol. 2002 Sep-Oct;25(5):251-3</Citation><ArticleIdList><ArticleId IdType="pubmed">12410055</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Metab Dispos. 2001 Feb;29(2):100-2</Citation><ArticleIdList><ArticleId IdType="pubmed">11159797</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacing Clin Electrophysiol. 2007 Dec;30(12):1579-82</Citation><ArticleIdList><ArticleId IdType="pubmed">18070319</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2000 Apr 1;47(7):655-61</Citation><ArticleIdList><ArticleId IdType="pubmed">10745059</ArticleId></ArticleIdList></Reference><Reference><Citation>Ment Health Clin. 2016 Mar 8;6(1):21-27</Citation><ArticleIdList><ArticleId IdType="pubmed">29955443</ArticleId></ArticleIdList></Reference><Reference><Citation>Ther Drug Monit. 2011 Feb;33(1):21-4</Citation><ArticleIdList><ArticleId IdType="pubmed">21157400</ArticleId></ArticleIdList></Reference><Reference><Citation>Antimicrob Agents Chemother. 2007 Nov;51(11):4098-104</Citation><ArticleIdList><ArticleId IdType="pubmed">17846135</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Pharmacother. 2002 May;36(5):827-30</Citation><ArticleIdList><ArticleId IdType="pubmed">11978161</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Clin Pharm. 2011 Jun;33(3):484-92</Citation><ArticleIdList><ArticleId IdType="pubmed">21487738</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatr Pract. 2012 Sep;18(5):361-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22995963</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychopharmacol. 2002 Aug;22(4):366-70</Citation><ArticleIdList><ArticleId IdType="pubmed">12172335</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Pharmacother. 2002 Jul-Aug;36(7-8):1193-203</Citation><ArticleIdList><ArticleId IdType="pubmed">12086554</ArticleId></ArticleIdList></Reference><Reference><Citation>Ther Adv Psychopharmacol. 2017 Dec;7(12):251-264</Citation><ArticleIdList><ArticleId IdType="pubmed">29201344</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pharmacol Ther. 2005 Dec;78(6):664-74</Citation><ArticleIdList><ArticleId IdType="pubmed">16338282</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoepidemiol Drug Saf. 2008 Apr;17(4):336-44</Citation><ArticleIdList><ArticleId IdType="pubmed">18302302</ArticleId></ArticleIdList></Reference><Reference><Citation>Br Med Bull. 2015 Jun;114(1):169-79</Citation><ArticleIdList><ArticleId IdType="pubmed">25957394</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Med. 2020 Mar 31;9(4):</Citation><ArticleIdList><ArticleId IdType="pubmed">32244415</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1966 Feb 19;1(7434):407-9</Citation><ArticleIdList><ArticleId IdType="pubmed">4159787</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Iran</li></country></list><tree><country name="Iran"><noRegion><name sortKey="Mohebbi, Niayesh" sort="Mohebbi, Niayesh" uniqKey="Mohebbi N" first="Niayesh" last="Mohebbi">Niayesh Mohebbi</name></noRegion><name sortKey="Moghadamnia, Marjan" sort="Moghadamnia, Marjan" uniqKey="Moghadamnia M" first="Marjan" last="Moghadamnia">Marjan Moghadamnia</name><name sortKey="Mohebbi, Niayesh" sort="Mohebbi, Niayesh" uniqKey="Mohebbi N" first="Niayesh" last="Mohebbi">Niayesh Mohebbi</name><name sortKey="Nazari Taloki, Zahra" sort="Nazari Taloki, Zahra" uniqKey="Nazari Taloki Z" first="Zahra" last="Nazari Taloki">Zahra Nazari Taloki</name><name sortKey="Shakiba, Alia" sort="Shakiba, Alia" uniqKey="Shakiba A" first="Alia" last="Shakiba">Alia Shakiba</name><name sortKey="Talebi, Ali" sort="Talebi, Ali" uniqKey="Talebi A" first="Ali" last="Talebi">Ali Talebi</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000852 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000852 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32855778
|texte= Drug Interactions of Psychiatric and COVID-19 Medications.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32855778" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidChloroV1
| This area was generated with Dilib version V0.6.38. |  |